Literature DB >> 7920083

Hematophagic histiocytosis: a clinicopathologic analysis of 23 cases with special reference to the association with peripheral T-cell lymphoma.

C S Chang1, C H Wang, I J Su, Y C Chen, M C Shen.   

Abstract

The clinicopathologic features of 23 patients with hematophagic histiocytosis (HH) are described. All of them exhibited increased histiocytes associated with hemophagocytosis in the marrow. The patients usually presented with fever, hepatosplenomegaly, lymphadenopathy, and cytopenia. The underlying illnesses were heterogeneous, including non-Hodgkin's lymphoma in 17, systemic lupus erythematosus in one, diabetes mellitus in one, acute myelomonocytic leukemia in one, myelodysplastic syndrome in one, and unknown cause in two. Among 17 non-Hodgkin's lymphoma, 14 were peripheral T-cell lymphoma, two were B-cell lymphoma, and one was an undefined phenotype. Among 14 patients with peripheral T-cell lymphoma, six of the patients had nasal T-cell lymphoma. Five of these 14 patients initially diagnosed as malignant histiocytosis turned out to be T-lineage lymphoma after immunophenotypic studies. Active infections, most of viral origin, were documented in eight patients, including Epstein-Barr virus in three, cytomegalovirus in three, herpes simplex virus in three, Pseudomonas aeruginosa in one, Bacteroides vulgatus in one, and mycoplasma in one. Some of them had mixed virus and bacteria infection. Sixteen (70%) of our patients died of their acute illness within 10 weeks of the diagnosis of HH. In the past, the clinical and histologic differentiation between hematophagic histiocytosis and true histiocytic neoplasm (histiocytic medullary reticulosis/malignant histiocytosis) has proved difficult, but now these can be distinguished with immunohistologic, immunogenetic, and cytogenetic studies, especially in the cases of peripheral T-cell lymphoma with hemophagocytic syndrome.

Entities:  

Mesh:

Year:  1994        PMID: 7920083

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  7 in total

1.  Enteric Fever presenting as secondary hemophagocytic lymphohistiocytosis.

Authors:  Meenu Pandey; Bhavna Dhingra; Sunita Sharma; Jagdish Chandra; Harish Pemde; Varinder Singh
Journal:  Indian J Pediatr       Date:  2012-03-14       Impact factor: 1.967

2.  Atypical histiocytosis in the lung.

Authors:  Hong Li; Weijun Cao; Huiping Li; Rongxuan Zhang; Ying Zhou; Jinfu Xu; David H Garfield
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

3.  The serum cytokine profiles of lymphoma-associated hemophagocytic syndrome: a comparative analysis of B-cell and T-cell/natural killer cell lymphomas.

Authors:  Tatsuharu Ohno; Yasunori Ueda; Ken-ichi Nagai; Takayuki Takahashi; Yoshiteru Konaka; Teruyuki Takamatsu; Takayo Suzuki; Masataka Sasada; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

4.  Drug associated vanishing bile duct syndrome combined with hemophagocytic lymphohistiocytosis.

Authors:  Hui Li; Xin Li; Xiao-Xing Liao; Hong Zhan; Yan Xiong; Chun-Lin Hu; Hong-Yan Wei; Xiao-Li Jing
Journal:  World J Gastrointest Endosc       Date:  2012-08-16

Review 5.  Hemophagocytic lymphohistiocytosis (HLH): a review of literature.

Authors:  Rohtesh S Mehta; Roy E Smith
Journal:  Med Oncol       Date:  2013-10-09       Impact factor: 3.738

Review 6.  Hemophagocytic syndromes and infection.

Authors:  D N Fisman
Journal:  Emerg Infect Dis       Date:  2000 Nov-Dec       Impact factor: 6.883

7.  Fulminant hemophagocytic lymphohistiocytosis secondary to a reactivated EBV infection: a case report.

Authors:  Pantelis Antonodimitrakis; Cecilia Wassberg; Spyridon Gerovasileiou; Johan Back; Roger Hällgren; Björn Olsen
Journal:  Ups J Med Sci       Date:  2013-03       Impact factor: 2.384

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.